HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.

AuthorsEvgeny Klyuchnikov, Philippe Schafhausen, Nicolaus Kröger, Tim H Brummendorf, Okay Osanmaz, Svetlana Asenova, Tatjana Zabelina, Sunday Ocheni, Francis Ayuk, Axel R Zander, Ulrike Bacher
JournalActa haematologica (Acta Haematol) Vol. 122 Issue 1 Pg. 6-10 ( 2009) ISSN: 1421-9662 [Electronic] Switzerland
PMID19602874 (Publication Type: Journal Article)
Chemical References
  • Aniline Compounds
  • Benzamides
  • Nitriles
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Quinolines
  • Thiazoles
  • bosutinib
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases
  • nilotinib
  • Dasatinib
Topics
  • Aged
  • Aniline Compounds (therapeutic use)
  • Benzamides
  • Dasatinib
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (drug therapy)
  • Male
  • Middle Aged
  • Nitriles (therapeutic use)
  • Piperazines (therapeutic use)
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (drug therapy)
  • Protein Kinase Inhibitors (therapeutic use)
  • Protein-Tyrosine Kinases (antagonists & inhibitors)
  • Pyrimidines (therapeutic use)
  • Quinolines (therapeutic use)
  • Stem Cell Transplantation
  • Thiazoles (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: